 IRVINE, Calif.--BUSINESS WIRE--Axonics Modulation Technologies, Inc. NASDAQ: AXNX, a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation SNM devices for the treatment of urinary and bowel dysfunction, is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on December 1-2, 2020. In advance of the virtual conference and investor meetings, a pre-recorded fireside chat with Raymond W. Cohen, CEO of Axonics, will 